梯瓦制药（Teva）周五盘中股价大跌5.01%，跌幅显著。这一下跌主要源于公司最新宣布的大规模裁员计划。
据悉，梯瓦制药于5月8日宣布，计划裁减约2900个工作岗位，占其员工总数的8%。此次裁员旨在削减7亿美元成本，以助力公司在2027年实现30%的运营利润率目标。目前，梯瓦制药的员工总数刚超过3.6万人。
这一裁员计划是梯瓦战略转型的关键部分。公司正逐步从单纯的仿制药企业向生物制药公司转型。这一转型将围绕三大核心展开：组织架构现代化、优化资源分配以及合理管控外部支出。虽然此举可能有助于提高公司的长期盈利能力，但短期内可能会对公司运营和员工士气产生影响，这也是导致投资者信心受挫、股价下跌的主要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.